Literature DB >> 23261080

Human enterovirus 71 strains in the background population and in hospital patients in Finland.

Hanna Honkanen1, Sami Oikarinen, Outi Pakkanen, Tanja Ruokoranta, Minna M Pulkki, Olli H Laitinen, Sisko Tauriainen, Sanna Korpela, Maija Lappalainen, Tytti Vuorinen, Anna-Maija Haapala, Riitta Veijola, Olli Simell, Jorma Ilonen, Mikael Knip, Heikki Hyöty.   

Abstract

BACKGROUND: Human enterovirus 71 (HEV71) is a common cause of severe outbreaks of hand-foot- and mouth disease, aseptic meningitis and encephalitis in Asian populations but has not caused such epidemics in all populations.
OBJECTIVES: To analyze the frequency of HEV71 in the background childhood population in Finland by screening in stool and serum samples and by measuring neutralizing antibodies against HEV71 in serum and to compare the genetic relationship of virus strains detected in asymptomatic children and those causing severe illness in Finland to the strains found in other countries. STUDY
DESIGN: 4185 stool samples and 5686 serum samples were collected and clinical symptoms recorded from children who were observed from birth. Additional stool samples were available from four children hospitalized due to EV71 infection. Samples were screened for the presence of RNA of human enteroviruses using RT-PCR and HEV71 amplicons were identified by sequencing. Phylogenetic analyses were carried out to study genetic relationships between different virus strains. Neutralizing antibodies against HEV71 were screened from 522 children.
RESULTS: A total of 0.3% of stool samples and two serum samples from healthy children were positive for HEV71 genome. 1.6% of the children had neutralizing antibodies against HEV71. Most infections were asymptomatic or mild in contrast to the clear symptoms in the children hospitalized due to HEV71. All viruses were C strains.
CONCLUSIONS: HEV71 is circulating in Finland but it is rare. No clear difference was seen between strains circulating in the Finnish background population and those found in hospitalized patients or those causing severe outbreaks worldwide.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23261080     DOI: 10.1016/j.jcv.2012.11.018

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  15 in total

1.  Detection of enteroviruses in stools precedes islet autoimmunity by several months: possible evidence for slowly operating mechanisms in virus-induced autoimmunity.

Authors:  Hanna Honkanen; Sami Oikarinen; Noora Nurminen; Olli H Laitinen; Heini Huhtala; Jussi Lehtonen; Tanja Ruokoranta; Minna M Hankaniemi; Valérie Lecouturier; Jeffrey W Almond; Sisko Tauriainen; Olli Simell; Jorma Ilonen; Riitta Veijola; Hanna Viskari; Mikael Knip; Heikki Hyöty
Journal:  Diabetologia       Date:  2017-01-09       Impact factor: 10.122

2.  Enterovirus RNA in longitudinal blood samples and risk of islet autoimmunity in children with a high genetic risk of type 1 diabetes: the MIDIA study.

Authors:  Ondrej Cinek; Lars C Stene; Lenka Kramna; German Tapia; Sami Oikarinen; Elisabet Witsø; Trond Rasmussen; Peter A Torjesen; Heikki Hyöty; Kjersti S Rønningen
Journal:  Diabetologia       Date:  2014-07-23       Impact factor: 10.122

3.  Relative sensitivity of immunohistochemistry, multiple reaction monitoring mass spectrometry, in situ hybridization and PCR to detect Coxsackievirus B1 in A549 cells.

Authors:  Jutta E Laiho; Maarit Oikarinen; Sarah J Richardson; Gun Frisk; Julius Nyalwidhe; Tanya C Burch; Margaret A Morris; Sami Oikarinen; Alberto Pugliese; Francesco Dotta; Martha Campbell-Thompson; Jerry Nadler; Noel G Morgan; Heikki Hyöty
Journal:  J Clin Virol       Date:  2016-02-02       Impact factor: 3.168

4.  Epidemiological Characteristics and Spatial-Temporal Clusters of Hand, Foot, and Mouth Disease in Zhejiang Province, China, 2008-2012.

Authors:  Juanjuan Gui; Zhifang Liu; Tianfang Zhang; Qihang Hua; Zhenggang Jiang; Bin Chen; Hua Gu; Huakun Lv; Changzheng Dong
Journal:  PLoS One       Date:  2015-09-30       Impact factor: 3.240

Review 5.  Human enterovirus 71 epidemics: what's next?

Authors:  Cyril C Y Yip; Susanna K P Lau; Patrick C Y Woo; Kwok-Yung Yuen
Journal:  Emerg Health Threats J       Date:  2013-09-10

6.  Prediction of Protection against Asian Enterovirus 71 Outbreak Strains by Cross-neutralizing Capacity of Serum from Dutch Donors, The Netherlands.

Authors:  Sabine M G van der Sanden; Gerrit Koen; Hetty van Eijk; Sylvie M Koekkoek; Menno D de Jong; Katja C Wolthers
Journal:  Emerg Infect Dis       Date:  2016-09       Impact factor: 6.883

Review 7.  MicroRNA and Pathogenesis of Enterovirus Infection.

Authors:  Bing-Ching Ho; Pan-Chyr Yang; Sung-Liang Yu
Journal:  Viruses       Date:  2016-01-06       Impact factor: 5.048

8.  Prevalence of enteroviruses in healthy populations and excretion of pathogens in patients with hand, foot, and mouth disease in a highly endemic area of southwest China.

Authors:  Qiang Wu; Xiaoqing Fu; Lili Jiang; Rusong Yang; Jianping Cun; Xiaofang Zhou; Yongming Zhou; Yibing Xiang; Wenpeng Gu; Jianhua Fan; Hong Li; Wen Xu
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

9.  Prevalence of enteroviruses in children with and without hand, foot, and mouth disease in China.

Authors:  Xiaoai Zhang; Hongyu Wang; Shujun Ding; Xianjun Wang; Xiaodan Chen; Ying Wo; Liyuan Wang; Doudou Huang; Wei Liu; Wuchun Cao
Journal:  BMC Infect Dis       Date:  2013-12-27       Impact factor: 3.090

10.  The variations of VP1 protein might be associated with nervous system symptoms caused by enterovirus 71 infection.

Authors:  Bao Zhang; Xianbo Wu; Keyong Huang; Ling Li; Li Zheng; Chengsong Wan; Ming-Liang He; Wei Zhao
Journal:  BMC Infect Dis       Date:  2014-05-07       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.